Metraipolis › archive › dc_e4fdbcf7c346

The NRF2 signaling pathway in hepatocellular carcinoma: dual roles, epigenetic reprogramming, and therapeutic opportunities in metabolic vulnerability — Europe PMC PMID:42621384

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42621384
DOI
10.3389/fonc.2026.1874956
License (as archived)
solo-consultazione
Archived
2026-10-17T01:37:02.657Z
SHA-256 of the archived text
0c006be35b7780225e42c4a09ac22735ed662fdda4dc8e232da1581611176601
Stable URL of this page
https://metraipolis.com/documento/dc_e4fdbcf7c346

How to cite

The NRF2 signaling pathway in hepatocellular carcinoma: dual roles, epigenetic reprogramming, and therapeutic opportunities in metabolic vulnerability — Europe PMC PMID:42621384 — Europe PMC (en), https://europepmc.org/article/MED/42621384 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e4fdbcf7c346 (Metraipolis archive dc_e4fdbcf7c346, sha256 0c006be35b7780225e42c4a09ac22735ed662fdda4dc8e232da1581611176601)
BibTeX
@misc{dce4fdbcf7c346,
  title = {The NRF2 signaling pathway in hepatocellular carcinoma: dual roles, epigenetic reprogramming, and therapeutic opportunities in metabolic vulnerability — Europe PMC PMID:42621384},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42621384},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e4fdbcf7c346; sha256 0c006be35b7780225e42c4a09ac22735ed662fdda4dc8e232da1581611176601},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42621384. Agents can read the archived copy with the MCP tool read_document.